Geneesmiddeleninformatiebank

1. What [Nationally completed name] is and what it is used for
[Nationally completed name] belongs to a group of medicines used to treat epilepsy and peripheral neuropathic pain (long lasting pain caused by damage to the nerves).

The active substance in [Nationally completed name] is gabapentin.

[Nationally completed name] is used to treat:

- Various forms of epilepsy (seizures that are initially limited to certain parts of the brain, whether the seizure spreads to other parts of the brain or not). The doctor treating you or your child 6 years of age and older will prescribe [Nationally completed name] to help treat epilepsy when the current treatment is not fully controlling the condition. You or your child 6 years of age and older should take [Nationally completed name] in addition to the current treatment unless told otherwise. [Nationally completed name] can also be used on its own to treat adults and children over 12 years of age.

- Peripheral neuropathic pain (long lasting pain caused by damage to the nerves). A variety of different diseases can cause peripheral neuropathic pain (primarily occurring in the legs and/or arms), such as diabetes or shingles. Pain sensations may be described as hot, burning, throbbing, shooting, stabbing, sharp, cramping, aching, tingling, numbness, pins and needles etc.

Een uitgebreide beschrijving van de werkzaamheid en mogelijke bijwerkingen van dit geneesmiddel vindt u in de patiëntenbijsluiter en samenvatting van de productkenmerken.

• Registratienummer:RVG 33681
•  
• Procedurenummer:NL/H/0763/002
•  
• Datum
  verstrekking
  handelsvergunning:07 augustus 2007
•  
• Handelsvergunninghouder:Sandoz B.V.
  Hospitaaldreef 29
  1315 RC ALMERE
•